Your browser doesn't support javascript.
loading
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.
Wei, Spencer C; Levine, Jacob H; Cogdill, Alexandria P; Zhao, Yang; Anang, Nana-Ama A S; Andrews, Miles C; Sharma, Padmanee; Wang, Jing; Wargo, Jennifer A; Pe'er, Dana; Allison, James P.
Afiliación
  • Wei SC; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: scwei@mdanderson.org.
  • Levine JH; Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
  • Cogdill AP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Zhao Y; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Anang NAS; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Andrews MC; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Sharma P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Wargo JA; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer
  • Pe'er D; Computational and Systems Biology Program, Sloan Kettering Institute, New York, NY 10065, USA.
  • Allison JP; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: jallison@mdanderson.org.
Cell ; 170(6): 1120-1133.e17, 2017 Sep 07.
Article en En | MEDLINE | ID: mdl-28803728
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Melanoma / Metástasis de la Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Subgrupos de Linfocitos T / Antígeno CTLA-4 / Receptor de Muerte Celular Programada 1 / Melanoma / Metástasis de la Neoplasia Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: Cell Año: 2017 Tipo del documento: Article